Lenvatinib Plus Camrelizumab versus Lenvatinib Monotherapy as Post-Progression Treatment for Advanced Hepatocellular Carcinoma: A Short-Term Prognostic Study

Fuqun Wei,1,* Qizhen Huang,2,* Jian He,1 Liuping Luo,1 Yongyi Zeng1 1Department of Hepatopancreatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, People’s Republic of China; 2Department of Radiation Oncology, Mengchao Hepatobiliary Hospital of...

Full description

Bibliographic Details

Published in:	Cancer Management and Research
Main Authors:	Wei F, Huang Q, He J, Luo L, Zeng Y
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-05-01
Subjects:	advanced hepatocellular carcinoma lenvatinib pd-1
Online Access:	https://www.dovepress.com/lenvatinib-plus-camrelizumab-versus-lenvatinib-monotherapy-as-post-pro-peer-reviewed-fulltext-article-CMAR